SS

Sagar Shashikant Shah

Active Director Director DIN 07006690
DIN 07006690 First appointment Nov 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2014
Shareholding value •••• Premium profile

About Sagar Shashikant Shah

Data last updated:

Sagar Shashikant Shah is a Director at Resonant Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Resonant Pharmaceuticals Private Limited reported revenue of ₹14.67 Cr (FY 2025).

DIN 07006690
Primary Designation Director
Industry Pharma
First Appointment 26 Nov 2014
Oldest Company Age 11 yrs
Largest company Resonant Pharmaceuticals Private Limited · ₹14.67 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Nov 20142014₹14.67 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Resonant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sagar Shashikant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sagar Shashikant Shah

Sagar Shashikant Shah currently holds 1 directorship: Resonant Pharmaceuticals Private Limited (Director, since 26 Nov 2014, revenue ₹14.67 Cr (FY 2025)).

Sagar Shashikant Shah was first appointed on 26 Nov 2014 as Director at Resonant Pharmaceuticals Private Limited.

The current boards of Sagar Shashikant Shah's companies include Ankit Deepak Bhargava (Resonant Pharmaceuticals Private Limited), Birju Rajendra Shah (Resonant Pharmaceuticals Private Limited), Jay Dipak Patel (Resonant Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available